Differences in costs of and access to pharmaceutical products in the EU
The report reviews the approaches that Member States have used to regulate the pharmaceutical market on both the supply and demand sides, and assesses evidence regarding the impact of these different approaches on pharmaceutical prices, cost-containment, industry innovation. It also considers the implications for patient access to pharmaceuticals. The report considers policy options to strengthen coordination among Member States and exchange best practice.
(Quelle: Europäisches Parlament, Politikbereich öffentliche Gesundheit; Stand: 22.03.2011)